Omicron, the latest SARS-CoV-2 variant of concern, has caused global alarm since being identified in South Africa. The variant has more than 50 mutations. People with impaired immunity take longer to clear a SARS-CoV-2 infection, giving the virus more opportunity to mutate. Medical News Today investigated whether the high incidence of HIV in southern Africa might have provided the conditions needed for Omicron to evolve.
It is becoming a familiar scenario — just as countries start to believe they might be getting COVID-19 under control, along comes another
The latest SARS-CoV-2 variant,
Evidence is growing that the variant may have been around for longer. And although it was identified in South Africa, it could have evolved elsewhere.
Omicron has more than 50 mutations, of which
Although SARS-CoV-2 mutates at a
The World Health Organization (WHO) designated Omicron, or B.1.1.529, a variant of concern on
“In an immunocompromised patient we treated, […] a large number of mutations had occurred over a relatively short time — this led us to the theory that the rapid spread of Alpha began with an immunocompromised individual.”
– Dr. Steven Kemp, research associate, University of Cambridge, Department of Medicine, UK.
One theory gaining ground is that the high levels of HIV in South Africa might have provided an ideal environment for the variant to evolve.
“The high prevalence of HIV in South Africa may have contributed to the evolution of the Omicron variant.” Dr. Kemp told Medical News Today. “However,” he added, “it is important to emphasize that HIV is not the only disease [that] can cause immunosuppression in individuals.”
According to UNAIDS, in South Africa in 2020, almost 1 in 5 of those aged 15–45 years were HIV positive. Of these,
“People living with HIV who control their virus are immunocompetent and are able to clear the virus like the rest of us,” Dr. Kemp commented.
However, this does leave a large number of people with suppressed immunity due to HIV. Could they be a reservoir for viral mutations?
Dr. Moritz Gerstung, Group Leader at the Computational Cancer Biology of the EMBL-European Bioinformatics Institute, believes this to be the case: “The regional emergence of several SARS-CoV-2 variants with long branches and concerning mutations in southern Africa suggests that its HIV epidemic is a driving factor.”
Although scientists know little about the severity of Omicron, no deaths have, so far, been linked to the variant. Some experts suggest that it may cause milder COVID-19 symptoms than previous variants, although it is too early to tell.
There is also the question of whether vaccines will be effective against the new variant.
“Mutations found in the Delta and Omicron variants have been shown to partially evade immunity granted by existing vaccines, but they still afford high protection and result in far fewer ventilations and deaths.”
– Dr. Steven Kemp.
Until more is known, experts advise vaccination, mask wearing, physical distancing, and ventilation to reduce the likelihood of infection, particularly for those with impaired immunity.
While Omicron dominates the headlines, the Delta variant, against which vaccines are effective, is still responsible for
Whether HIV contributed to the development of Omicron or not, experts widely believe that uneven vaccination rollout worldwide contributes to the evolution of SARS-CoV-2 variants.
“There is a lack of vaccines available to African and lower income countries,” Dr. Kemp said. “Unvaccinated populations do provide reservoirs for viruses to mutate and multiply.”
A recent Nature
As the United Nations High Commissioner for Refugees warned earlier this year: “No one is safe until everyone is safe.”